MedPath

the Oral Medications with the Panchakarma is treatment is given for Obesity induced Fibroid Uterus

Phase 2
Conditions
Health Condition 1: N72- Inflammatory disease of cervix uteriHealth Condition 2: N85- Other noninflammatory disorders ofuterus, except cervix
Registration Number
CTRI/2024/04/066450
Lead Sponsor
CCRAS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosed cases of Fibroid Uterus on the basis of Ultrasonography of the Abdomen and Pelvis.

2. Subjects(participants) who are having the size of Fibroid up to 5 cm.

3. Patients having a B.M.I. 25 - 30 (moderate obesity).

4. Female patient with age limitation of 25 to 55.

5. Patients having clinical features of Fibroid Uterus.

Exclusion Criteria

1. Subjects(participants) who do not fulfill the inclusion criteria will be excluded from the study.

2. Disorders of reproductive tract such as Congenital anomalies, Tuberculosis, Carcinoma.

3. Subjects(participants) suffering with any Chronic illness, Uncontrolled metabolic disorders and systemic diseases.

4. Subjects(participants) suffering with HIV/VDRL/HBsAg/STD’s will be excluded.

5. Subjects(participants) who are having the Fibroid Size more than 5 cm.

6. Patients who are unfit for Basti.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath